The multiple sclerosis it is a social emergency. 130 thousand people in Italy are affected by this chronic, unpredictable and progressively disabling disease that affects the central nervous system, and which is the leading cause of disability among young people. It affects women with a 3 to 1 ratio to men. And a diagnosis is recorded every 3 hours with 3,600 new cases per year. Are some data presented in the course of ‘1000azionioltrelaSm: co-responsibility, innovation, sustainability towards the 2025 agenda’, webinar organized at the end of World Multiple Sclerosis Day and to open the National Week dedicated to the disease, promoted by Aism (Italian Multiple Sclerosis Association) and its Fism Foundation.
Multiple sclerosis is diagnosed between the ages of 20 and 40 in the prime of working age. In about 3-5% of all people with multiple sclerosis, the onset of the disease occurs under 16 years of age (pediatric cases). Between direct and indirect costs, a total annual cost of the disease is estimated at around 6 billion euros.
It is, says Mario Alberto Battaglia, president of the Fism Foundation, the research arm of Aism, of “a disease for which research is in full swing. 40 million have been invested only with research financed by Aism with its Fism Foundation. of euro in the last 5 years. There are 117 active research groups and we have ongoing projects worth 16 million euro. There are 664 publications on the disease in the last 5 years. And we have guaranteed immediate scientific research on Covid and multiple sclerosis, impact on the disease, therapies and vaccinations. An Italian research that is always fundamental to the advancement of knowledge in every field but above all – he concludes – with a concrete impact on the life and prospects of people with multiple sclerosis and related diseases. person with multiple sclerosis is at the center of research strategy choices “.